Clicks Group Ltd CLS

Morningstar Rating
ZAC24,000.00 −303.00 (1.25%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CLS is trading at a LOCK|J?gP>$ premium.
Price
ZAR 243.03
Fair Value
LOCK|?.%FDz#<lz
Uncertainty
LOCK|wMMfS
1-Star Price
LOCK|t.kMn^p?vz
5-Star Price
LOCK|B.k$<n%
Economic Moat
LOCK|JF?yf
Capital Allocation
—

Trading Information

Previous Close Price
ZAC24,303.00
Day Range
ZAC23,953.00–24,698.00
52-Week Range
ZAC18,366.00–38,618.00
Bid/Ask
ZAC23,500.00 / ZAC24,350.00
Shares Outstanding
231.71M
Market Cap
ZAC5.56T
Volume/Avg
2M / 2M

Key Statistics

Price/Earnings (Normalized)
16.71
Price/Sales
1.12
Dividend Yield (Trailing)
3.73%
Dividend Yield (Forward)
3.73%
Dividend Payment Schedule
Jan, Jul
Total Yield
6.40%

Company Profile

Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Core
Total Number of Employees
20,682

Valuation

Metric
CLS
Price/Earnings (Normalized)
16.71
Price/Book Value
9.03
Price/Sales
1.12
Price/Cash Flow
10.42
Price/Earnings
CLS

Financial Strength

Metric
CLS
Quick Ratio
0.39
Current Ratio
1.05
Interest Coverage
12.05
Quick Ratio
CLS

Profitability

Metric
CLS
Return on Assets (Normalized)
15.05%
Return on Equity (Normalized)
51.59%
Return on Invested Capital (Normalized)
33.22%
Return on Assets
CLS

Pharmaceutical Retailers Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
JD Health International Inc
JDHIF
—LOCK|HTLKg$15B
JD Health International Inc ADR
JDHIY
—LOCK|>@NC$15B
Raia Drogasil SA ADR
RADLY
—LOCK|H!P$S$7B
Alibaba Health Information Technology Ltd ADR
ALBBY
—LOCK|@<NJ&$6B
Alibaba Health Information Technology Ltd
ALBHF
—LOCK|S@y>$6B
Clicks Group Ltd ADR
CLCGY
—LOCK|F@%w%$3B
Clicks Group Ltd
CCKRF
—LOCK|ghPW$3B
COSMOS Pharmaceutical Corp
CSMYF
—LOCK|%R&$3B
Redcare Pharmacy NV ADR
SAEYY
—LOCK|&^$2B
High Tide Inc
HITI
—LOCK|%#>$227M

Sponsor Center